← Back to all trials
Completed
NCT05434286
Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in Cirrhosis With Hepatorenal Syndrome-Acute Kidney Injury
Conditions: Hepatorenal Syndrome, Cirrhosis, Liver, Acute-On-Chronic Liver Failure, AKI, Refractory Ascites
Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: No
Enrollment: 140
Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh
Location: PGIMER Chandigarh National Capital Territory of Delhi
Summary
Point-of-care echocardiography (POC-Echo) is used to determine left ventricular systolic and diastolic dysfunction (LVDD), inferior vena cava (IVC) dynamics and volume status in cirrhosis and Acute-on-chronic liver failure ACLF accurately.
We will assess IVC dynamics, LV systolic function \[LV ejection fraction (EF) \& cardiac output (CO)\], and diastolic dysfunction (E/e', e' and E/A ratio) and urinary biomarkers (cystatin C and NGAL) in patients with cirrhosis and ACLF with hepatorenal syndrome-acute kidney injury (HRS-AKI).
Eligibility Criteria
Inclusion Criteria:
* Cirrhosis of any Etiology
* Patient with acute kidney injury meeting HRS-AKI criteria
Exclusion Criteria:
* Hepatocellular carcinoma
* Patients with active variceal bleeding
* HIV or severe immunocompromised state
* Chronic kidney disease (CKD) on renal replacement therapy (RRT),
* Previous transjugular intra hepatic portosystemic shunt (TIPS)
* Porto-pulmonary hypertension,
* Coronary artery disease
* Congenital or valvular heart disease
* Prosthetic cardiac valves
Source: ClinicalTrials.gov (NCT05434286). StuddyBuddy aggregates publicly available trial information.